Antiphospholipid Antibodies in Critically Ill Patients With COVID‐19

OBJECTIVE: Coagulopathy is one of the characteristics observed in critically ill patients with coronavirus disease 2019 (COVID‐19). Antiphospholipid antibodies (aPLs) contribute to coagulopathy, though their role in COVID‐19 remains unclear. This study was undertaken to determine the prevalence and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Arthritis Rheumatol
Egile Nagusiak: Xiao, Meng, Zhang, Yan, Zhang, Shulan, Qin, Xuzhen, Xia, Peng, Cao, Wei, Jiang, Wei, Chen, Huan, Ding, Xin, Zhao, Hua, Zhang, Hongmin, Wang, Chunyao, Zhao, Jing, Sun, Xuefeng, Tian, Ran, Wu, Wei, Wu, Dong, Ma, Jie, Chen, Yu, Zhang, Dong, Xie, Jing, Yan, Xiaowei, Zhou, Xiang, Liu, Zhengyin, Wang, Jinglan, Du, Bin, Qin, Yan, Gao, Peng, Lu, Minya, Hou, Xin, Wu, Xian, Zhu, Huadong, Xu, Yingchun, Zhang, Wen, Li, Taisheng, Zhang, Fengchun, Zhao, Yongqiang, Li, Yongzhe, Zhang, Shuyang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
COVID‐19
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7361932/
https://ncbi.nlm.nih.gov/pubmed/32602200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.41425
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak